NASDAQ: ORMPOramed Pharmaceuticals Inc Stock Ownership - Who owns Oramed Pharmaceuticals?
Insider buying vs selling
Have Oramed Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Miriam Kidron | Chief Scientific Officer | 2026-03-30 | 435,084 | $3.31 | $1.44MSell |
| Nadav Kidron | President and CEO | 2026-03-30 | 44,818 | $3.31 | $148.35kSell |
ORMP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ORMP insiders and whales buy or sell their stock.
ORMP Shareholders
What type of owners hold Oramed Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Zeev Bronfeld | 16.29% | 6,589,767 | $26.56M | Insider |
| Nadav Kidron | 8.77% | 3,548,243 | $14.30M | Insider |
| Bml Capital Management LLC | 7.83% | 3,167,231 | $12.76M | Institution |
| Regals Capital Management LP | 6.53% | 2,640,460 | $10.64M | Insider |
| Benjamin Shapiro | 5.00% | 2,023,220 | $8.15M | Insider |
| Aquamarine Financial Cayman Ltd | 4.88% | 1,973,057 | $7.95M | Institution |
| Sb Capital Management Inc | 4.70% | 1,900,000 | $7.66M | Institution |
| Murchinson Ltd | 3.31% | 1,340,247 | $5.40M | Institution |
| David Mark Slager | 3.25% | 1,316,328 | $5.30M | Insider |
| Joshua Hexter | 2.87% | 1,160,384 | $4.68M | Insider |
ORMP vs Biotech Stocks
Oramed Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.